ClearPoint Neuro Q1 2024 GAAP EPS $(0.16) Beats $(0.19) Estimate, Sales $7.639M Beat $6.994M Estimate

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 30.43 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $7.639 million which beat the analyst consensus estimate of $6.994 million by 9.23 percent. This is a 40.60 percent increase over sales of $5.433 million the same period last year.